Table 1.
No. | Title | Status | Conditions | Interventions | Locations |
---|---|---|---|---|---|
1 | Maternal-Foetal Transmission of SARS-Cov-2 | Recruiting |
Maternal fetal infection transmission COVID-19 SARS-CoV 2 |
Diagnostic test: diagnosis of SARS-Cov2 by RT-PCR and IgG, Ig M serologies in the amniotic fluid, the blood cord, and the placenta | • CHR Orléans, Orléans, France |
2 | COVID-19 Breastfeeding Guideline for African-Americans | Not yet recruiting |
COVID-19 Exclusive breastfeeding |
Behavioral: COVID-19 breastfeeding support | • Meharry Medical College, Nashville, TN, USA |
3 | Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) | Not yet recruiting | COVID-19 | Diagnostic test: diagnostic tests for COVID-19 infection | |
4 | The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic | Active, not recruiting | COVID | Diagnostic test: COVID 19 diagnostic test | • Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong |
5 | Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury | Recruiting | COVID-19 | Other: lung CT scan analysis in COVID-19 patients |
• Ospedale Papa Giovanni XXIII, Bergamo, Italy • Policlinico San Marco-San Donato group, Bergamo, Italy • Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy • ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy • ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy • ASST Monza, Monza, Italy • AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy • Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino, San Marino |
6 | Study Evaluating the Safety and Efficacy of Autologous Non-hematopoietic Peripheral Blood Stem Cells in Covid-19 | Completed | Coronavirus disease 2019 (COVID-19) |
Biological: autologous non-hematopoietic peripheral blood stem cells (NHPBSC) Drug: COVID-19 standard care |
• Abu Dhabi Stem Cells Center, Abu Dhabi, United Arab Emirates |
7 | Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus | Recruiting | High sensitivity and specificity (with 95% confidence interval) of RealDetect™ COVID-19 RT-PCR Kit | Device: performance evaluation study of RealDetect RT-PCR Kit for COVID-19 detection | • Institute of Epidemiology, Disease Control and Research (IEDCR), Mohakhali, Dhaka (for sample collection and sample storage), Institute for Developing Science & Health Initiatives (ideSHi); Mohakhali, Dhaka (for sample analysis, data collection, data analysis), Dhaka, Bangladesh |
8 | Diagnostic Value of Patient-Reported and Clinically Verified Olfactory Disorders (COVID-19) | Completed | COVID-19 | Biological: reporting of anosmia, ageusia, and other clinical symptoms | • Uhmontpellier, Montpellier, France |
9 | Smell and Taste Disorders in COVID-19 Patients | Recruiting | COVID-19 | Other: investigation of smell and taste disorders | • ASST Monza-Ospedale San Gerardo, Monza, Italy |
10 | Neonatal Complications of Coronavirus Disease (COVID-19) | Recruiting | Neonatal COVID-19 disease | Other: no intervention—exposure is to COVID-19 | • Imperial College, London, UK |
11 | COVID-19 Infection in Patients with Hepatocellular Carcinoma | Recruiting |
Hepatocellular carcinoma COVID-19 |
Diagnostic test: nasopharyngeal COVID-19 RT-PCR | • CHU Amiens, Amiens, France |
12 | COVID-19 Prevalence and Cognitive Deficits in Neurological Patients | Not yet recruiting |
Neurological diseases or conditions Stroke, acute Seizure disorder |
Diagnostic test: COVID-19 swap test PCR |
• Aalborg University Hospital, Aalborg, DK, Denmark • Aarhus University Hospital, Aarhus, DK, Denmark • Regional Hospital West Jutland, Hostebro, Holstebro, DK, Denmark • Regional Hospital Central Jutland, Viborg, Viborg, DK, Denmark |
13 | Frailty in Elderly Patients with COVID-19 | Recruiting | COVID-19 | Other: relation between frailty and clinical outcomes in elderly patients with COVID-19 | • ASST Monza-Ospedale San Gerardo, Monza, Italy |
14 | COVID-19 Convalescent Plasma (CCP) Transfusion | Recruiting | COVID-19 | Biological: COVID convalescent plasma | • University of Mississippi Medical Center, Jackson, MS, USA |
15 | COVID-19 in the Swedish ICU-Cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality | Not yet recruiting |
COVID-19 Critical illness |
Other: COVID-19 and intensive care | |
16 | MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study | Enrolling by invitation | COVID-19 | Other: COVID-19 PCR and serology testing | • Duke CTSI Translational Population Health Office, Kannapolis, NC, USA |
17 | Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID) | Active, not recruiting | COVID-19 | Diagnostic test: ELISA and Rapid test to detect antibodies against COVID-19 | • Parc Tauli University Hospital, Sabadell, Barcelona, Spain |
18 | The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications | Enrolling by invitation |
COVID-19 Coronavirus infection SARS-CoV-2 Complications |
Other: complex diagnostic panel | • Silesian Centre for Heart Disease, Zabrze, Silesia, Poland |
19 | COVID19-Convalescent Plasma for Treating Patients with Active Symptomatic COVID 19 Infection (FALP-COVID) | Recruiting |
COVID-19 infection Cancer patients General population |
Biological: convalescent plasma from COVID-19 donors | • Fundacion Arturo Lopez Perez, Providencia, Santiago, Chile |
20 | COVID-19 Endoscopy Survey | Completed | COVID-19 | Other: practice details |
• Kings County Hospital Center, Brooklyn, NY, USA; Albertson, NY, USA • Faculty of Medicine, Zagazig University, Zagazig, Sharkia, Egypt • Al-Azhar Univerisity, Cairo, Egypt • Ahvaz Imam hospital, Ahvaz, Iran, Islamic Republic of |
21 | Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals | Recruiting | COVID-19 | • Cliniques Universitaires Saint Luc, Brussels, Belgium | |
22 | COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department | Enrolling by invitation | COVID-19 | Diagnostic test: COVID-19 test, polymerase chain reaction for SARS-CoV-2 | • Rigshospitalet University Hospital of Copenhagen, Copenhagen, Denmark |
23 | Viral Infection and Respiratory Illness Universal Study [VIRUS]: COVID-19 Registry | Recruiting | Coronavirus | Other: observational |
• Mayo Clinic in Arizona, Scottsdale, AZ, USA • Mayo Clinic in Florida, Jacksonville, FL, USA • Society of Critical Care Medicine (150+ sites), Chicago, IL, USA • Rahul Kashyap, Rochester, MN, USA |
24 | Predictive Factors COVID-19 Patients | Recruiting | COVID-19 | Other: predictive factors for clinical response in patients with COVID-19 | • ASST Monza-Ospedale San Gerardo, Monza, Italy |
25 | Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt | Not yet recruiting |
Characteristic diseases Outcome, fatal |
Other: follow-up | |
26 | Detection of Anti-COVID-19 Antibody Levels in an Hospital Population | Recruiting | COVID-19 | Diagnostic test: detection of anti-COVID-19 antibody level | • Humanitas Rozzano/San Pio X, Rozzano, Lombardia, Italy |
27 | Isotretinoin in Treatment of COVID-19 | Not yet recruiting | COVID-19 | Drug: isotretinoin only product in oral dose form | |
28 | Convalescent Plasma for Patients with COVID-19: a Pilot Study | Not yet recruiting |
Coronavirus Coronavirus infection |
Drug: plasma | • Universidad del Rosario, Bogota, Cundinamarca, Colombia |
29 | Slovenian National COVID-19 Prevalence Study | Recruiting |
COVID-19 SARS-CoV-2 |
Diagnostic test: no intervention planned due to the observational study design—only a diagnostic testing | • University of Ljubljana, Ljubljana, Slovenia |
30 | Incidence of COVID-19 Test Conversion in Post-surgical Patients | Recruiting | SARS-CoV-2 | Diagnostic test: COVID-19 PCR and serology |
• North Shore University Hospital, Manhasset, NY, USA • Long Island Jewish Medical Center, New Hyde Park, NY, USA |
31 | Novel COVID-19, a National Analysis | Recruiting | COVID-19 | Other: prevalence of COVID-19 | • Assiut University Hospitals, Assiut, Egypt |
32 | Convalescent Plasma for Patients with COVID-19: a Randomized, Open Label, Parallel, Controlled Clinical Study | Not yet recruiting |
Coronavirus Coronavirus infection |
Drug: plasma Drug: hydroxychloroquine |
• Universidad del Rosario, Bogota, Cundinamarca, Colombia |
33 | Methodist Health System COVID-19 Patient Registry | Not yet recruiting | COVID-19 | Other: treatment for COVID-19 | • Clinical Research Institute Methodist Health System, Dallas, TX, USA |
34 | Safety and Efficacy of Melatonin in Outpatients Infected with COVID-19 | Not yet recruiting | COVID-19 |
Drug: melatonin Other: placebo (methylcellulose) capsule |
• University at Buffalo, Buffalo, NY, USA |
35 | Discovery Stage (Proof-of-Concept) COVID-19 Antigen Presentation Therapeutic Vaccine | Active, not recruiting | COVID-19 |
Biological: COVID-19 therapeutic vaccine - Nucleocapsid-GM-CSF protein lactated Ringer’s injection |
• Medicine Invention Design Incorporation (MIDI) - IORG0007849, North Bethesda, MD, USA |
36 | Dynamic Evaluation of COVID-19 Diagnostic Tests | Not yet recruiting | COVID-19 | Diagnostic test: COVID-19 diagnostic test | |
37 | NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression | Not yet recruiting | COVID-19 |
Genetic: whole genome analysis Genetic: T cell receptor (TCR) repertoire Genetic: SARS-CoV-2 viral composition |
|
38 | Beaumont Health Large-Scale Automated Serologic Testing for COVID-19 | Recruiting |
COVID-19 Coronavirus infection Severe acute respiratory syndrome coronavirus 2 |
Diagnostic test: EUROIMMUN assay |
• Beaumont Health System, Royal Oak, MI, USA • Beaumont Health, Royal Oak, MI, USA |
39 | Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic | Recruiting | Pregnancy | Diagnostic test: COVID 19 diagnostic test by PCR | • University Hospital of Toulouse, Toulouse, France |
40 | Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients | Recruiting | COVID-19 | Procedure: CT-scan with minimal invasive autopsy | • Jessa Hospital, Hasselt, Belgium |
41 | Exchange Transfusion Versus Plasma from Convalescent Patients with Methylene Blue in Patients with COVID-19 | Recruiting | COVID-19 |
Biological: exchange blood transfusion from normal donor Biological: plasma from convalescent patients with COVID-19 Drug: Methylene Blue 5 MG/ML |
• Ain Shams University, Cairo, Egypt |
42 | Clinical Characteristics and Outcomes of Pediatric COVID-19 | Recruiting |
COVID-19 SARS-CoV-2 infection Pediatric ALL Pneumonia, viral Pandemic response |
Other: exposure (not intervention)—SARS-CoV-2 infection | • University of Calgary/Alberta Children’s Hospital, Calgary, Alberta, Canada |
43 | Relation Between Lab Finding and COVID-19 Severity | Not yet recruiting | COVID-19 |
Diagnostic test: D-dimer, CBC. ESR, CRP Diagnostic test: liver function tests, serum ferritin, and PCR for COVID-19 |
|
44 | Setting Up a COVID-19 Care Facility at a Prison in Pakistan | Completed | COVID-19 | Other: COVID-19 facility | • Camp Jail/COVID-19 care facility/SIMS, Lahore, Pakistan |
45 | Impact of COVID-19 on Marshallese Communities in the U.S. | Not yet recruiting | COVID-19 | Other: assessing impact of COVID-19 | |
46 | Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients | Recruiting | COVID-19 | Diagnostic test: CT scan | • Tepecik Training and Research Hospital, Izmir, Izmir, Konak, Turkey |
47 | Antibody Based Tests for SARSCOV-2 COVID-19-Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings | Recruiting | COVID-19 | Diagnostic test: CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test | • St. David’s Medical Center, Austin, TX, USA |
48 | Spartan COVID-19 System: Evaluation of Clinical Sample Collection | Recruiting | COVID-19 | Device: Spartan COVID-19 System |
• Humber River Hospital, North York, Ontario, Canada • The University of Ottawa Heart Institute, Ottawa, Ontario, Canada |
49 | Classification of COVID-19 Infection in Posteroanterior Chest X-rays | Completed | COVID-19 | Device: CovX | • Dascena, Oakland, CA, USA |
50 | Rapid, Onsite COVID-19 Detection | Enrolling by invitation |
COVID-19 SARS-CoV-2 |
Device: Rapid Onsite COVID-19 detection | • University of Wisconsin, Madison, WI, USA |
51 | Safety and Efficacy Of Hydroxychloroquine for At Risk Population (SHARP) Against COVID-19 | Not yet recruiting |
Coronavirus infection Hydroxychloroquine adverse reaction |
Drug: hydroxychloroquine sulfate 200 mg (mg) tab | |
52 | Validation of COVID-19 Tests | Active, not recruiting | COVID-19 |
Diagnostic test: Covid-19 Rapid Test Kit (RAPG-COV-019) Diagnostic test: quantitative IgG test |
• Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge, London, UK |
53 | Pulmonary Optical Coherence Tomography in COVID-19 Patients | Recruiting |
COVID-19 Pulmonary embolism |
Diagnostic test: optical coherence tomography (OCT) |
• Incor - Heart Institute - University of Sao Paulo, São Paulo, Brazil • IRCCS San Raffaele, Milano, Italy |
54 | COVID-19 Surveillance Based on Smart Wearable Device | Not yet recruiting | COVID-19 | • Peking University First Hospital, Beijing, Beijing, China | |
55 | Descriptive and Retrospective Analysis of Acute Myocarditis Associated with Pandemic COVID-19 in Children | Not yet recruiting | COVID-19 |
• Hôpital Bicêtre, Le Kremlin-Bicêtre, France • Hôpital Armand Trousseau, Paris, France • Hôpital Necker-Enfants Malades, Paris, France • Hôpital Robert Debré, Paris, France |
|
56 | Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers | Not yet recruiting | COVID-19 | Diagnostic test: COVID-19 antibodies testing | |
57 | A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients | Recruiting | COVID-19 |
Drug: suspension of heat killed (autoclaved) Mycobacterium w Drug: standard therapy of COVID-19 |
• All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India • All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India • Postgraduate Institute of Medical Education and Research, Chandigarh, India • All lndia Institute of Medical Science, Delhi, Delhi, India |
58 | Convalescent Plasma In ICU Patients With COVID-19-Induced Respiratory Failure | Recruiting |
COVID-19 SARS-CoV-2 |
Biological: multiple doses of anti-SARS-CoV-2 convalescent plasma |
• 8700 Beverly Blvd., Los Angeles, CA, USA • Johns Hopkins University, Baltimore, MD, USA |
59 | Immunoglobulin G Antibody Immune Response Profile Following Infection with SARS-CoV-2 in COVID-19 Egyptian Patients | Recruiting | COVID-19 | • Sohag University Hospital, Sohag, Egypt | |
60 | Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection | Recruiting | Severe acute respiratory syndrome coronavirus 2 | Biological: COVID-19 convalescent plasma | • Hospital Clínico Universidad Católica, Santiago, Chile |
61 | Will Hydroxychloroquine Impede or Prevent COVID-19 | Recruiting |
COVID-19 Coronavirus Coronavirus infections SARS-CoV-2 |
Drug: Hydroxychloroquine—daily dosing Drug: hydroxychloroquine—weekly dosing Other: placebo oral tablet Diagnostic test: monitoring visit—baseline Diagnostic test: monitoring visit—week 4 Diagnostic test: monitoring visit—week 8 Other: weekly assessment |
• Henry Ford Hospital, Detroit, MI, USA • Detroit Department of Transportation (DDOT), Detroit, MI, USA • Detroit Fire Department & Detroit EMS, Detroit, MI, USA • Detroit Police Department, Detroit, MI, USA |
62 | Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19: a Randomized Control Trial | Not yet recruiting |
SARS-CoV-2 infections COVID-19 |
Drug: oral | • Assistant Professor Subsai Kongsaengdao, Bangkok, Thailand |
63 | Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) | Recruiting | COVID-19 | Other: data monitoring for 48 h within the first 12 h of admission for COVID-19 |
• Louis Mourier hospital (AP-HP), Colombes, France • Brabois Hospital (CHRU de Nancy), Vandœuvre-lès-Nancy, France |
64 | Effects on the Qt Interval of COVID-19 Coronavirus Infection | Recruiting |
Coronavirus infection Intensive care patients |
• Servicio de Anestesia, Hospital General Universitario Gregorio Marañon, Madrid, Spain | |
65 | COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients with Pneumonia Caused by SARS- CoV-2 | Recruiting | COVID-19 | Biological: COVID-19 convalescent plasma | • Hospital of the University of Pennsylvania, Philadelphia, PA, USA |
66 | COVID-19 Pandemic and Worldwide Organ Procurement | Recruiting | COVID-19 | • Paris Transplant Group, Paris, France | |
67 | Testing the Accuracy of a Digital Test to Diagnose Covid-19 | Recruiting | COVID-19 | Diagnostic test: COVID-19 swab PCR test | • King’s College London, London, United Kingdom |
68 | Clinical Trial of Allogeneic Mesenchymal Cells from Umbilical Cord Tissue in Patients with COVID-19 | Recruiting | COVID |
Biological: mesenchymal cells Drug: standard of care |
• Hospital Universitario de Getafe, Getafe, Madrid, Spain • Hospital Universitario de Cruces, Barakaldo, Spain • Hospital Universitario de La Princesa, Madrid, Spain • Hospital Infantil Universitario Niño Jesus, Madrid, Spain • Hospital Ramón Y Cajal, Madrid, Spain • Complejo Universitario La Paz, Madrid, Spain |
69 | The Heart Hive COVID-19 Study | Not yet recruiting |
COVID-19 Cardiomyopathies |
Other: COVID-19 experience surveys | • Imperial College London, London, UK |
70 | National Survey of Symptoms of People Aged 70 and Overs Diagnosed with COVID-19 | Completed |
SARS-CoV-2 COVID-19 |
Other: observation | • Angers University Hospital, Angers, France |
71 | Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic | Recruiting |
COVID-19 Health personnel Personnel, hospital |
Other: serial seroconversion measurements in hospital employees during the COVID-19 pandemic |
• Nordsjællands Hospital, Hillerød, Capital Region, Denmark • Nykøbing Falster County Hospital, Nykøbing Falster, Southern Region, Denmark |
72 | Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals | Not yet recruiting | COVID-19 |
Biological: adsorbed COVID-19 (inactivated) vaccine Biological: placebo |
• Universidade de Brasília, Brasilia, DF, Brazil • Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil • Hospital das Clínicas da Universidade Federal do Paraná, Curitiba, PR, Brazil • Hospital São Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS, Brazil • Hospital das Clínicas da UNICAMP, Campinas, SP, Brazil • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirao Preto, SP, Brazil • Instituto de Infectologia Emílio Ribas, Sao Paulo, SP, Brazil • Centro de Pesquisas Clínicas do Instituto Central do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil • Instituto Israelita de Ensino e Pesquisa Albert Einstein, Sao Paulo, SP, Brazil • Universidade Municipal de São Caetano do Sul, São Caetano do Sul, SP, Brazil • Faculdade de Medicina de São José do Rio Preto - FAMERP, São José Do Rio Preto, São Paulo, Brazil • Instituto de Infectologia Evandro Chagas - Fiocruz, Rio De Janeiro, Brazil |
73 | Gut Microbiota, “Spark and Flame” of COVID-19 Disease | Recruiting | COVID-19 | Other: exposure |
• Hospital CUF Infante Santo, S.A., Lisbon, Portugal • Hospital de São Francisco Xavier, Lisbon, Portugal • Centro Hospitalar Universitário São João, Oporto, Portugal |
74 | Antioxidant Therapy for COVID-19 Study | Not yet recruiting | COVID-19 |
Dietary supplement: antioxidation therapy Other: standard of care |
• Abia State Isolation Centre, Amachara, Umuahia, Abia State, Nigeria • Benue State University Teaching Hospital, Makurdi, Benue State, Nigeria • Brigadier Abba Kyari Memorial Hospital, Borno, Borno State, Nigeria • University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria • University of Calabar Teaching Hospital, Calabar, Cross River, Nigeria • Federal Medical Centre Idi-Aba, Abeokuta, Ogun State, Nigeria • Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria • Infectious Disease Hospital, Amanawa, Sokoto State, Nigeria • Murtala Muhammad Speciaist Hospital, Sokoto, Sokoto State, Nigeria • Occupational Therapy Center, Sokoto, Sokoto State, Nigeria • Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State, Nigeria |
75 | COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) | Recruiting | COVID-19 | Other: BioMedomics COVID-19 IgM-IgG Rapid Test | • AO San Paolo, Milan, IT, Italy |
76 | Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic | Completed | COVID-19 | Diagnostic test: COVID-19 diagnostic PCR | • Seda Yilmaz Semerci, Istanbul, Turkey |
77 | Inhaled Nitric Oxide for Preventing Progression in COVID-19 | Recruiting | COVID-19 | Drug: nitric oxide | • Tufts Medical Center, Boston, MA, USA |
78 | Cohort of Patients Infected with SARS-CoV2 (COVID-19) or Suspected of Being | Recruiting | COVID-19 | Other: blood samples | • GH Pitié-Salpêtrière / Service d’Accueil des Urgences, Paris, Ile- de-France, France |
79 | Hydrogen-Oxygen Generator with Nebulizer in the Improvement of Symptoms in Patients Infected with COVID-19 | Recruiting | COVID-19 |
Device: oxyhydrogen Device: oxygen |
• First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China |
80 | Endovascular Thrombectomy in COVID-19 Infected Patients | Completed |
Ischemic stroke COVID-19 |
Other: mechanical trombectomy | • Uhmontpellier, Montpellier, France |
81 | Pre-exposure Prophylaxis with Hydroxychloroquine for High- Risk Healthcare Workers During the COVID-19 Pandemic | Suspended | COVID-19 |
Drug: hydroxychloroquine Drug: placebos |
• ISGlobal, Barcelona, Spain |
82 | Evaluating Clinical Parameters of COVID-19 in Pregnancy | Not yet recruiting |
COVID-19 2019 novel coronavirus infection COVID-19 infection |
• Chelsea and Westminster Hospital NHS Foundation Trust, London, UK | |
83 | Characteristics of COVID-19 Infection Among PREGnant Women | Recruiting |
Coronavirus infection Pregnancy related |
Other: COVID-19 positive via testing | • INOVA Health System, Falls Church, VA, USA |
84 | Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia | Active, not recruiting |
COVID-19 SARS-CoV-2 |
• Uh Montpellier, Montpellier, France | |
85 | Implementation of Physiotherapy on COVID-19 Patients in ICU | Recruiting |
SARS-CoV-2 COVID-19 |
Other: physiotherapy | • Uhmontpellier, Montpellier, France |
86 | Tableted COVID-19 Therapeutic Vaccine | Active, not recruiting | COVID-19 | Biological: V-SARS |
• Immunitor Inc., Vancouver, BC - British Columbia, Canada • Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo, Mongolia |
87 | Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-Associated Complications in Hospitalized Patients | Recruiting |
COVID-19 SARS-CoV-2 |
Biological: COVID-19 convalescent plasma (CCP) Biological: placebo |
• San Francisco General Hospital, San Francisco, CA, USA • UCSF Medical Center at Mount Zion, San Francisco, CA, USA • University of California, San Francisco Medical Center (Parnassus Campus), San Francisco, CA, USA |
88 | Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19 | Recruiting | COVID-19 |
Device: Kerecis oral and nasal spray Other: placebo |
• National Hospital of Iceland (Landspítali), Reykjavík, Iceland |
89 | Anti COVID-19 Convalescent Plasma Therapy | Not yet recruiting | COVID-19 | Biological: anti-SARS-CoV-2 convalescent plasma | |
90 | Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study | Not yet recruiting | COVID-19 | Other: deep venous disease diagnostic | • Red de Investigacion Vascular (SEACV), Madrid, Spain |
91 | Elmo Respiratory Support Project - COVID-19 | Not yet recruiting |
COVID-19 Respiratory failure with hypoxia |
Other: Elmo Project at COVID-19: study in humans Device: Elmo Project at COVID-19: proof of concept and usability |
|
92 | Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia | Recruiting | COVID-19 pneumonia |
Drug: plasma from COVID-19 convalescent patient Drug: human immunoglobulin |
• Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico |
93 | Observational Cohort of COVID-19 Patients at Raymond- Poincare | Recruiting | COVID-19 | • Department of Infectiology, Raymond Poincaré Hospital, APHP, Garches, France | |
94 | Longitudinal Energy Expenditure and Metabolic Effects in Patients with COVID-19 (LEEP-COVID) | Recruiting | COVID-19 |
Device: Q-NRG Metobolic Cart Device Device: MuscleSound Ultrasound Device: multifrequency bioimpedance spectroscopy |
• Duke University Medial Center, Durham, NC, USA |
95 | Part Two of Novel Adoptive Cellular Therapy with SARS- CoV-2 Specific T Cells in Patients with Severe COVID-19 | Recruiting | COVID-19 | Biological: SARS-CoV-2 specific T cells |
• Changi General Hospital, Singapore, Singapore • KK Women’s and Children’s Hospital, Singapore, Singapore • National University Hospital, Singapore, Singapore • Sengkang General Hospital, Singapore, Singapore • Singapore General Hospital, Singapore, Singapore |
96 | A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients with COVID-19 Infection | Recruiting | COVID-19 | Biological: anti-SARS-CoV-2 convalescent plasma | • Froedtert Hospital, Milwaukee, WI, USA |
97 | Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic | Recruiting |
COVID-19 interstitial pneumonia |
• IRCCS Policlinico San Donato, San Donato Milanese, MI, Italy | |
98 | CORonavirus (COVID-19) Diagnostic Lung UltraSound Study | Not yet recruiting | COVID-19 | Diagnostic test: lung ultrasound | |
99 | Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19 | Not yet recruiting | Coronavirus disease 2019 (COVID-19) |
Biological: COVID-19 convalescent plasma Biological: anti-COVID-19 human immunoglobulin Drug: standard (specific) therapy for COVID-19 |
• LifeFactors Zona Franca SAS, Medellín, Antioquia, Colombia |
100 | Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients | Not yet recruiting | COVID-19 |
Drug: tramadol Other: standard care delivered in the isolation hospitals |